Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Barbara Kosacz currently holds 28,000 shares of Kronos Bio, Inc. (KRON), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Barbara Kosacz has been a net buyer of KRON stock. They have purchased $99.8K and sold $12.6K worth of shares.
Barbara Kosacz's most recent insider trade was on Apr 9, 2026, when they sold 28,000 shares at $0.00 per share.
Barbara Kosacz serves as Executive at Kronos Bio, Inc. (KRON). They have executed 10 insider transactions totaling $112.3K over their tenure at the company.
Barbara Kosacz holds the position of Executive at Kronos Bio, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Barbara Kosacz has shown a buying trading pattern, with $99.8K in total purchases and $12.6K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Barbara Kosacz was on Oct 14, 2020, when they purchased $99.8K worth of KRON shares. This transaction involved 5,250 shares at $19.00 per share.
Barbara Kosacz currently owns 28,000 shares of Kronos Bio, Inc. (KRON), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Barbara Kosacz's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Barbara Kosacz has 10 Form 4 filings on record as an insider at Kronos Bio, Inc..
Set alerts for Barbara Kosacz and 40,000+ other insiders.